Small- and medium-sized pharmaceutical companies in survival crisis

For decades, the Korea Pharmaceutical Industry Cooperative (KPIC) was a solid advocate of the country’s small- and medium sized pharmaceutical firms.

While it is trying to raise its voice to make its public sentiment more favorable to member companies, the organization is now facing a new crisis of survival.

In dealing with the government-initiated new drug price reform, the lobby group ...